Q1 2024 · 13F-HR
Paradigm Biocapital Advisors LPholdings as filed
Filed 2024-05-15 · accession 0001855655-24-000005
$2.84B
Reported value
34
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $313.7M | 11.0% | 4,177,830 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $265.5M | 9.35% | 3,818,095 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $217.4M | 7.65% | 552,120 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $148.8M | 5.24% | 2,389,902 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $146.3M | 5.15% | 3,124,749 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $139.6M | 4.91% | 1,078,346 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $116.2M | 4.09% | 1,787,176 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $111.2M | 3.91% | 1,982,006 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $107.9M | 3.80% | 2,614,935 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $107.0M | 3.77% | 2,484,874 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $104.1M | 3.66% | 2,863,406 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $98.5M | 3.47% | 2,330,508 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $93.9M | 3.31% | 2,914,975 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $89.5M | 3.15% | 7,903,600 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $88.1M | 3.10% | 5,031,420 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $84.7M | 2.98% | 1,239,995 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $84.1M | 2.96% | 2,121,163 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $80.8M | 2.85% | 3,246,759 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $76.8M | 2.70% | 507,952 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $66.9M | 2.35% | 3,135,387 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $44.6M | 1.57% | 2,446,373 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $41.0M | 1.44% | 6,425,803 | Common | SOLE |
| 984241109 | YMABUSD | Y-MABS THERAPEUTICS INC | $36.3M | 1.28% | 2,233,610 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $29.6M | 1.04% | 2,818,908 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $25.8M | 0.91% | 799,054 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $23.0M | 0.81% | 1,348,015 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $21.9M | 0.77% | 330,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $19.9M | 0.70% | 2,390,988 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $15.3M | 0.54% | 6,457,293 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $14.9M | 0.52% | 944,917 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $11.7M | 0.41% | 400,000 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $11.2M | 0.39% | 2,172,620 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $3.3M | 0.12% | 147,959 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $1.2M | 0.04% | 50,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.